6.9
Adrenerge agonisten: Therapeutische classificatie
Adrenerge agonisten kunnen worden ingedeeld op basis van hun therapeutisch gebruik en werkingsmechanismen. Ze hebben verschillende doeleinden in klini…
Adrenergic agonists are classified based on their mechanism of action. Additionally, sympathomimetics can also be categorized by their therapeutic actions.
Pressor agents, or vasopressors, are used to elevate low blood pressure. These include endogenous catecholamines, such as noradrenaline, and synthetic agents like phenylephrine.
They also serve as cardiac stimulants by increasing the heart rate, the force of contractility, and conduction velocity.
Bronchodilators include β2-agonists such as salbutamol and terbutaline. They relax lung muscles and widen the airways, making breathing easier.
α-agonists like oxymetazoline and phenylephrine act as decongestants. They help relieve nasal congestion and clear blocked noses.
Noncatecholamine sympathomimetics, such as amphetamine, act as CNS stimulants. They induce restlessness, euphoria, and insomnia through the release of DA and serotonin.
β2-agonists like ritodrine are used to relax the uterus and delay premature labor.
View the full transcript and gain access to JoVE Core videos
Q1: What are pressor agents and how do they work?
Pressor agents, or vasopressors, elevate low blood pressure and function as cardiac stimulants by increasing heart rate, force of contractility, and conduction velocity. Examples include endogenous catecholamines like noradrenaline and synthetic agents such as phenylephrine, making them essential for managing hypotensive conditions and supporting cardiovascular function.
Q2: How do beta-2 agonists relieve respiratory symptoms?
Beta-2 agonists like salbutamol and terbutaline relax bronchial muscles and widen airways, making breathing easier for patients with obstructive pulmonary disorders and asthma. These drugs reduce airway constriction and improve airflow by directly relaxing lung smooth muscle tissue through receptor activation.
Q3: What is the mechanism of action for decongestants?
Alpha-agonists like oxymetazoline and phenylephrine act as decongestants by constricting blood vessels in nasal tissues, reducing swelling and congestion. This vasoconstriction of the nasal mucosa helps relieve stuffy or blocked noses and sinuses by decreasing tissue edema and improving airflow through nasal passages.
Q4: How do indirect-acting CNS stimulants produce their effects?
Noncatecholamine sympathomimetics like amphetamine act as indirect-acting CNS stimulants by triggering the release of dopamine and serotonin rather than binding directly to receptors. These neurotransmitters induce restlessness, euphoria, and insomnia, distinguishing indirect-acting agents from direct-acting agents that bind adrenergic receptors.
Q5: What role do beta-2 agonists play in obstetrics?
Beta-2 agonists like ritodrine relax uterine smooth muscle and delay premature labor by reducing uterine contractions. By providing additional time for fetal development, these agents allow for interventions to improve maternal and fetal outcomes in at-risk pregnancies and support better neonatal health.
Q6: How are adrenergic agonists classified therapeutically?
Adrenergic agonists are classified based on their therapeutic actions and mechanisms of action. Major categories include vasopressors for blood pressure support, bronchodilators for airway relaxation, decongestants for nasal relief, CNS stimulants for neural effects, uterine relaxants for labor management, and beta-3 agonists for treating urinary incontinence.
Q7: What distinguishes catecholamine from noncatecholamine sympathomimetics?
Catecholamines like noradrenaline and dopamine are endogenous compounds that bind directly to adrenergic receptors, while noncatecholamine sympathomimetics like amphetamine lack the catechol moiety and work indirectly. Indirect agents trigger drugs affecting neurotransmitter release or uptake rather than direct receptor binding, producing different pharmacological profiles.